Drug intelligence / Profile preview

Amvitral Z

Development stage
Unknown
Lead developer
Amvia Biotech
Modality
Small Molecules
Administration
Oral
01

Overview

Amvitral Z is a multi-ingredient nutritional supplement and oral rehydration product developed by Amvia Biotech. It is formulated as an oral powder containing dextrose, sucrose, zinc, and copper sulphate, typically packaged in 105 gm or 210 gm containers. The product is designed to address electrolyte and trace element deficiencies, particularly those resulting from diarrhea-related fluid loss. Dextrose and sucrose facilitate the co-transport of sodium and water across the intestinal epithelium via the sodium/glucose cotransporter 1 (SGLT1), aiding in rapid rehydration. Zinc is included for its role in reducing the duration and severity of diarrheal episodes and supporting immune function, while copper sulphate provides additional essential mineral supplementation.

Brand names
Amvitral Z
02

Targets

SLC5A1 (Sodium Glucose Cotransporter 1)

Beyond the preview

Go deeper on Amvitral Z.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amvitral Z.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call